Skip to main content
OpenTrials

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,008 public trials 572 recruiting studies
Refine in advanced search Browse all conditions

Paraproteinemias trial results

Completed

Study of ACY-1215 in Combination With Lenalidomide, and Dexamethasone in Multiple Myeloma

NCT01583283

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • Sarah Cannon Research Institute Drug Development Unit Nashville, Tennessee, United States
View Trial Details
Completed

A Study of an Accelerated Infusion Rate of Daratumumab in Patients With Relapsed and Refractory Multiple Myeloma

NCT03697629

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Kingston Health Sciences Centre Kingston, Ontario, Canada
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
  • Hôpital Maisonneuve-Rosemont Montreal, Quebec, Canada
  • McGill University Health Centre Montreal, Quebec, Canada
View Trial Details
Completed

Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Multiple Myeloma

NCT03111992

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • Novartis Investigative Site Freiburg im Breisgau, Germany
  • Novartis Investigative Site Heidelberg, Germany
View Trial Details
Completed

Study of the Combination of Panobinostat and Carfilzomib in Patients With Relapsed/Refractory Multiple Myeloma

NCT01496118

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Florida Cancer Specialists South Fort Myers, Florida, United States
  • Woodlands Medical Specialists Pensacola, Florida, United States
  • Florida Cancer Specialists North St. Petersburg, Florida, United States
View all 13 locations
View Trial Details
Completed

Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis

NCT01078454

Conditions
Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +11 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • The Medical Center of Aurora Aurora, Colorado, United States
  • Boulder Community Hospital Boulder, Colorado, United States
View all 209 locations
View Trial Details
Completed

Optimising Renal Outcome in Myeloma Renal Failure

NCT02424851

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +25 more
Locations
  • Basingstoke & North Hampshire Hospital Basingstoke, United Kingdom
  • Heartlands Hospitals Birmingham, United Kingdom
  • Kent & Canterbury Hospital Canterbury, United Kingdom
  • St Helier Hospital Epsom, United Kingdom
View Trial Details

Related conditions